Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma [Phase 1, Phase 2]
This ClinicalTrials.gov update reports that results for the Phase 1/2a trial of oral BAL101553 in adults with solid tumors, glioblastoma, an…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies [Phase 1]
A Phase 1 trial evaluating Sym021 in combination with Sym022 or Sym023 (and with Irinotecan in some arms) in patients with recurrent advance…
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Phase I/II Study of Avelumab in Pediatric Cancer Participants [Phase 1]
A Phase I/II pediatric trial of avelumab in refractory or relapsed solid tumors and lymphoma was terminated, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Durvalumab in HIV-1 Patients With Solid Tumors [Phase 2]
Phase 2 study evaluating durvalumab in HIV-1 infected patients with solid tumors has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies [Phase 1]
Phase 1 trial evaluating LHC165 alone and with PDR001 in advanced solid tumors; the study has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E) [Phase 2]
Phase 2 MATCH subprotocol evaluating AZD9291 (osimertinib) as a targeted treatment for cancers with EGFR genetic changes; the trial is curre…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1) [Phase 2]
Phase 2 trial evaluating Erdafitinib (JNJ-42756493) for cancers with FGFR amplifications; the study includes advanced and refractory lymphom…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors [Phase 1, Phase 2]
Clinical trial of NOX66 with external beam radiotherapy in metastatic castration-resistant prostate cancer and other solid tumors was termin…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Performance Evaluation of Diagnostic Accuracy of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Population and in Cancer Free Population.
This clinical trial update reports the performance evaluation of the PanTum Detect diagnostic test for detecting solid tumors in both people…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors [Phase 1]
First-in-human Phase 1 study of IO-108 as a single agent and in combination with a PD-1 inhibitor in adults with advanced solid tumors has c…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors [Phase 1]
Completion of a Phase 1 dose-confirmation and dose-expansion study evaluating IO-108 alone and in combination with an Anti-PD-1 therapy in p…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: A Study of EMB-02 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
The clinical trial of EMB-02 for advanced solid tumors (Phase 1/2) has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors [Phase 3]
Phase 3 trial evaluating prophylactic antiviral therapy in patients with current or past hepatitis B infection receiving anti-cancer therapy…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors [Phase 1]
A Phase 1 study evaluating Axatilimab alone or in combination with Durvalumab in patients with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: ONO-4538 Phase I Study in Patients With Solid Tumor [Phase 1]
Phase I study of ONO-4538 (nivolumab) in patients with solid tumors has completed. The sponsor is Ono Pharmaceutical Co., Ltd.
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts [Phase 2]
Phase 2 clinical trial update evaluating safety, pharmacokinetics, and clinical effects of IV PT-112 in advanced solid tumors with dose expa…
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Durvalumab and Tremelimumab for Pediatric Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating durvalumab and tremelimumab in pediatric malignancies has results posted; the study is currently active but not r…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN [Phase 2]
Phase II, single-center randomized open-label trial evaluating the impact of serial procalcitonin measurements in patients with hematologic …
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations [Phase 2]
Phase 2 basket study of neratinib in solid tumors with somatic HER2 or EGFR exon 18 mutations was terminated; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 [Phase 1]
Phase 1 trial of intratumorally administered STING agonist E7766 in advanced solid tumors or lymphomas has been terminated with results post…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Study Of PF-04449913 Administered Alone In Select Solid Tumors [Phase 1]
Phase 1 trial evaluating PF-04449913 as a single agent in select solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2) [Phase 1, Phase 2]
A dose-escalation and cohort-expansion study of subcutaneously administered nemvaleukin alfa (ALKS 4230), alone and with pembrolizumab, in a…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001) [Phase 1]
Phase 1 study of Ulevostinag (MK-1454) alone or in combination with pembrolizumab (MK-3475) in participants with advanced/metastatic solid t…
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Phase I/Ib Multiple Ascending Dose Study in China [Phase 1]
Phase I/Ib multiple ascending dose trial in China for metastatic solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. [Phase 1, Phase 2]
Phase 1/2 trial evaluating OBI-888 for safe and effective dosing in patients with locally advanced or metastatic solid tumors; the study is …